British Journal of Pharmacology · 1994 · 88 citations · 7 references
Life SciencesPharmacologyPhysiologyNeuropharmacologyNeurophysiologyPharmacodynamicsCholinergic PharmacologyCholinergic SignalingNeuromuscular JunctionNeuromuscular PhysiologyNeurotransmissionNeurotransmitter Systems5-Hydroxytryptamine Receptor PharmacologyCholinergic AgonistsCholinergic ModulationCholinergic Receptor PharmacologyElectrical StimulationNeuromuscular Junction TransmissionSerotonin 5-Ht4 Receptor AgonistsUrinary Bladder Physiology
In human isolated detrusor strips, submaximal contractile responses evoked by electrical stimulation were resistant to hexamethonium (30 microM) and abolished by tetrodotoxin (0.6 microM) and hyoscine (1 microM), indicating the activation of postganglionic cholinergic nerves. In methysergide (1 microM) and ondansetron (3 microM) pretreated tissues, 5-hydroxytryptamine (5-HT) (0.3 nM-1 microM) caused a concentration-dependent increase in the amplitude of contractions (pEC50 = 8.1), which was antagonized by the selective 5-HT4 receptor antagonist GR 113808 (3, 10 and 30 nM) in a competitive manner. Schild analysis yielded a pA2 estimate of 8.9, a value comparable to that reported for GR 113808 in other animal and human peripheral tissues (8.8-9.7). Our findings indicate that neuromuscular cholinergic transmission in human isolated detrusor muscle is facilitated by neural 5-HT receptors belonging to the 5-HT4 subtype. The human urinary bladder can thus be regarded as an additional site in which 5-HT4 receptors are distributed.
7
Carlo Alberto Maggi, Riccardo Patacchini, Paolo Santicioli et al. · General Pharmacology The Vascular System · 1989 · 31 citations